Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates interstitial lung disease in SKG mice.
Sho SendoJun SaegusaHirotaka YamadaKeisuke NishimuraAkio MorinobuPublished in: Arthritis research & therapy (2019)
Tofacitinib facilitates the expansion of MDSCs in the lung and ameliorates ILD in SKG mice.